Five Polymorphisms and Breast Cancer Risk: Results from the Breast Cancer Association Consortium
Mia M. Gaudet, Isabel dos‐Santos‐Silva(London School of Hygiene & Tropical Medicine), Angela Cox, Hiltrud Brauch(German Cancer Research Center), Kati Kämpjärvi(Helsinki University Hospital), Peter Schürmann(Hannover Re (Germany)), Ellen L. Goode(Mayo Clinic in Arizona), Natalia Bogdanova(Medizinische Hochschule Hannover), Laura Baglietto, Julian Peto(London School of Hygiene & Tropical Medicine), Fergus J. Couch(Mayo Clinic), Dallas R. English, Graham G. Giles(The University of Melbourne), Jenny Chang‐Claude(Universität Hamburg), Annika Lindblom(Karolinska University Hospital), Irina Coinac(Medizinische Hochschule Hannover), Thilo Dörk(Hannover Re (Germany)), Gloría Ribas(Spanish National Cancer Research Centre), Alison M. Dunning(University of Cambridge), Roger L. Milne(The University of Melbourne), José Ignacio Arias(Spanish National Cancer Research Centre), Jonathan J. Morrison(Uniformed Services University of the Health Sciences), Javier Benı́tez(Spanish National Cancer Research Centre), Vesa Kataja(Kuopio University Hospital), Heli Nevanlinna(University of Helsinki), Christina Justenhoven(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), Diana Torres(German Cancer Research Center), Olivia Fletcher(Breast Cancer Care), Kirsimari Aaltonen(University of Helsinki), Sandrine Tchatchou(Mount Sinai Hospital), Ute Hamann(German Cancer Research Center), Nicola J. Camp(University of Utah), Ramona Salazar(Universität Hamburg), Dieter Flesch‐Janys, Stig E. Bojesen(University of Copenhagen), Børge G. Nordestgaard(Gentofte Hospital), Xianshu Wang(Kunming University of Science and Technology), Tuomas Heikkinen(University of Helsinki), Manjeet K. Humphreys(University of Cambridge), Janet E. Olson(Cornell University), Gianluca Severi(Inserm), Henrik L. Flyger(University of Copenhagen), Barbara Burwinkel(German Cancer Research Center), Rita K. Schmutzler(The University of Melbourne), Claus R. Bartram(Goethe University Frankfurt), Veli-Matti Kosma(University of Eastern Finland), Sascha Abbas(German Cancer Research Center), Sara Margolin(University of Copenhagen), Nichola Johnson(Institute of Cancer Research)
Cited by 69
Related Papers
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
|European Heart Journal|2013|2.7k
Body-Mass Index and Mortality among 1.46 Million White Adults
|New England Journal of Medicine|2010|2.3k